Actavis, Hisamitsu neurology news

Hisamitsu's Noven Pharmaceuticals Inc. subsidiary granted Actavis a non-exclusive, royalty-bearing license to market a generic version of Daytrana methylphenidate transdermal system for ADHD beginni...